Immunological Signatures in Blood and Urine in 80 Individuals Hospitalized during the Initial Phase of COVID-19 Pandemic with Quantified Nicotine Exposure.
Krzysztof LaudanskiMohamed A MahmoudAhmed Sayed AhmedKaitlin SusztakAmal MathewJames ChenPublished in: International journal of molecular sciences (2024)
This research analyzes immunological response patterns to SARS-CoV-2 infection in blood and urine in individuals with serum cotinine-confirmed exposure to nicotine. Samples of blood and urine were obtained from a total of 80 patients admitted to hospital within 24 h of admission (t adm ), 48 h later (t 48h ), and 7 days later (t 7d ) if patients remained hospitalized or at discharge. Serum cotinine above 3.75 ng/mL was deemed as biologically significant exposure to nicotine. Viral load was measured with serum SARS-CoV-2 S-spike protein. Titer of IgG, IgA, and IgM against S- and N-protein assessed specific antiviral responses. Cellular destruction was measured by high mobility group box protein-1 (HMGB-1) serum levels and heat shock protein 60 (Hsp-60). Serum interleukin 6 (IL-6), and ferritin gauged non-specific inflammation. The immunological profile was assessed with O-link. Serum titers of IgA were lower at t adm in smokers vs. nonsmokers ( p = 0.0397). IgM at t 48h was lower in cotinine-positive individuals ( p = 0.0188). IgG did not differ between cotinine-positive and negative individuals. HMGB-1 at admission was elevated in cotinine positive individuals. Patients with positive cotinine did not exhibit increased markers of non-specific inflammation and tissue destruction. The blood immunological profile had distinctive differences at admission (MIC A/B↓), 48 h (CCL19↓, MCP-3↓, CD28↑, CD8↓, IFNγ↓, IL-12↓, GZNB↓, MIC A/B↓) or 7 days (CD28↓) in the cotinine-positive group. The urine immunological profile showed a profile with minimal overlap with blood as the following markers being affected at t adm (CCL20↑, CXCL5↑, CD8↑, IL-12↑, MIC A/B↑, GZNH↑, TNFRS14↑), t 48h (CCL20↓, TRAIL↓) and t 7d (EGF↑, ADA↑) in patients with a cotinine-positive test. Here, we showed a distinctive immunological profile in hospitalized COVID-19 patients with confirmed exposure to nicotine.
Keyphrases
- sars cov
- heat shock protein
- smoking cessation
- emergency department
- oxidative stress
- coronavirus disease
- end stage renal disease
- ejection fraction
- chronic kidney disease
- liver injury
- healthcare
- newly diagnosed
- liver fibrosis
- immune response
- dendritic cells
- heat shock
- small molecule
- dna methylation
- heat stress
- genome wide
- acute care